ALB and neoplasm: The first nanotechnology‐based chemotherapeutic agent Abraxane (nab‐paclitaxel) is HSA‐bound paclitaxel.[15] The success of nab‐paclitaxel shows the potential of albumin as a drug carrier for tumor therapy.